Skip to main content
Clinical Trials/ISRCTN05214203
ISRCTN05214203CompletedNot Applicable

A prospective Longitudinal trial of the effect of Atomoxetine on cognitive, educational, behavioural, social and emotional wellbeing in students with Attention Deficit Hyperactivity Disorder

Australian Research Council (Australia)0 sites144 target enrollmentStarted: November 20, 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
144

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Boys and girls aged seven to 15 years
  • 2. Meet the Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV) criteria for ADHD, as determined by the referring paediatrician or child psychiatrist
  • 3. Participants are naive to atomoxetine medication

Exclusion Criteria

  • 1. A history of bipolar or psychotic disorder
  • 2. Tourette?s syndrome
  • 3. Substance abuse
  • 4. Serious medical illness
  • 5. Intellectual disability (Intelligence Quotient [IQ] less than 70)
  • 6. Pregnancy
  • 7. Non compliance with research protocol

Investigators

Similar Trials